As this chart from Deutsche Bank shows, the yield on the Italian 10-year is lower than it was even before Italy became a country. Deutsche Bank strategist Jim Reid attached proxies for Italian debt, such as from Naples, to chart pre-1861 data.
European stocks edged lower Tuesday, losing momentum after the pause of a key coronavirus trial as traders waited for earnings from some of the world’s leading banks.
The drug maker announced Monday night that the 60,000-patient, late-stage trials have been put on hold and new enrollment has been halted, citing “an unexplained illness in a study participant.”
A Nevada man became the first published case of COVID-19 reinfection in the U.S., adding to a growing number of examples worldwide signaling that patients who have recovered from the viral disease may still be at risk of getting it again.
The demands of at-home schooling and work amid the COVID-19 pandemic pushed the personal computer market to its strongest growth in more than a decade, according to third-party analyses released Monday.
Wall Street has given up on another big Washington financial-aid package for the economy before the Nov. 3 presidential election — but it still thinks another huge rescue package is coming.
Walt Disney Co. on Monday announced a strategic reorganization of its media and entertainment businesses to focus on streaming, sending shares higher in after-hours trading.
Walt Disney Co. on Monday announced a strategic reorganization of its media and entertainment businesses to focus on streaming, sending shares higher in after-hours trading.
European stocks traded higher Monday, helped by hopes of further stimulus on both sides of the Atlantic with the autumn spread of the coronavirus increasingly leading to tightened rules on activity.
President Donald Trump has called the antibody cocktail he received to fend off the coronavirus “a cure,” but the chief executive of Regeneron Pharmaceuticals Inc. said Sunday that Trump’s case is merely “a case of one,” and the treatment still needs more testing before its efficacy is known.